P2Y12 Inhibitor Intensity De-escalation in Patients With ACS P2Y12 Inhibitor Intensity De-escalation in Patients With ACS

A new meta-analysis assesses a DAPT de-escalation strategy based on modulation of DAPT intensity by switching from potent P2Y12 receptor inhibitors to clopidogrel in patients with ACS.European Heart Journal
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news